Spinal Cord Stimulation Devices Market: By Product Type, By Application, Complex Regional Pain Syndrome, Ischemic Pain, and Others), By End User, and Geography

Spinal Cord Stimulation Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Rechargeable Devices and Non-Rechargeable Devices), By Application (Failed Back Surgery Syndrome (FBSS), Complex Regional Pain Syndrome (CRPS), Ischemic Pain, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Neuro Clinics), and Region

Spinal Cord Stimulation Devices Market size was valued at US$ 2032.4 million in 2023 and is expected to reach US$ 3362 million by 2030, at a CAGR of 9.2% from 2024-2030. Spinal cord stimulation is a treatment that veils torment motions before they reach the mind. A little gadget, like a pacemaker, is embedded in the body to convey electric heartbeats to the Spinal cord. It enables patients to better deal with their incessant torment side effects and reduce the utilization of opioid drugs. It might be an alternative on the off chance that patients endure constant back, leg, or arm torment and have not discovered help with different treatments. The spreading mindfulness about the upsides of spinal cord stimulation for better torment administration by the medicinal services experts additionally pushes the request for a spinal rope incitement framework and drives the worldwide spinal line incitement framework showcase.

The cost viability of the SCS Devices Market when contrasted with other torment administration market medical procedures, expands the request of the spinal string incitement framework and drives the global spinal cord stimulation (SCS) market. However, spinal cord stimulation (SCS) may prompt difficulties, for example, nerve damage, decimating loss of motion, and other minor correctable issues which could hamper the request of the spinal string incitement framework and limit the development of the global Spinal Cord Stimulation Devices Market. The connection of the spinal cord stimulation system with the pacemakers, diathermy, helpful ultrasound, and MRI may bring about unforeseen changes in incitement and prompts the failure of devices, which may likewise limit the request of systems and development of the worldwide spinal cord stimulation system market.

The business has seen a recognizable pattern where organizations are choosing mergers and acquisitions to solidify their market position and extend their item portfolio. M&A is the snappiest strategy to enter new and quickly developing areas in the spinal line stimulators showcase. This technique likewise brings down the hazard connected to spinal string stimulators\' showcase passage. Another advantage of acquisitions is getting the most recent technology. As a few nations, for example, the U.S. move towards the responsible care display, the cost-adequacy of spinal string stimulators is anticipated to assume a noteworthy part amid the gauge time frame. An examination led by specialists at the Department of Neurology at the University of Saskatchewan Canada has demonstrated that spinal line stimulators are significantly more temperate than traditional medicinal administration in the treatment of ceaseless agony.

Spinal Cord Stimulation Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

Spinal Cord Stimulation Devices Market Dynamics

Spinal cord stimulation devices occupies significant space in the neurostimulation devices market. The expanding pattern of insignificantly minimally invasive surgery (MIM) is the key factor support the request of the spinal cord stimulation system and drives the global Spinal Cord Stimulation Devices Market.

The inclination of spinal cord stimulation system is expanding over the other regular medications as these medical procedures are by and large less agonizing, helps to fast recovery of disorder and also reduces the operative stress, which also drives the global SCS Devices Market. The spreading awareness about the advantages of spinal cord stimulation system for better pain management by the healthcare professionals, which additionally drives the worldwide spinal string incitement framework showcase.

Spinal Cord Stimulation Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2032.4 million

Market Size in 2030

US$ 3362 million

Market CAGR

9.2%

By product type

  • Rechargeable Devices
  • Non-Rechargeable Devices

By Application

  • Failed Back Surgery Syndrome (FBSS)
  • Complex Regional Pain Syndrome (CRPS)
  • Ischemic Pain
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Neuro Clinics

Key Features of the Report

  • The spinal cord stimulation devices market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

Spinal cord stimulation devices market size was valued at US$ 2032.4 million in 2023 and is set to reach US$ 3362 million by 2030 growing at a CAGR of 9.2%.

The spinal cord stimulation devices market key players are Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.)

Asia Pacific is the fastest growing region in spinal cord stimulation devices market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Spinal Cord Stimulation Devices Market Introduction 
2.1.Global Spinal Cord Stimulation Devices Market  - Taxonomy
2.2.Global Spinal Cord Stimulation Devices Market  - Definitions
2.2.1.Product Type 
2.2.2. Application
2.2.3.End Users
2.2.4.Region
3. Global Spinal Cord Stimulation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID-19 on Market
4. Global Spinal Cord Stimulation Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Spinal Cord Stimulation Devices Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Rechargeable Devices
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Non-Rechargeable Devices
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Spinal Cord Stimulation Devices Market  By  Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Failed Back Surgery Syndrome (FBSS)
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Complex Regional Pain Syndrome (CRPS)
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ischemic Pain
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Spinal Cord Stimulation Devices Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Neuro Clinics
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Spinal Cord Stimulation Devices Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Spinal Cord Stimulation Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Rechargeable Devices
9.1.2.Non-Rechargeable Devices
9.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Failed Back Surgery Syndrome (FBSS)
9.2.2.Complex Regional Pain Syndrome (CRPS)
9.2.3.Ischemic Pain
9.2.4.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers
9.3.3.Neuro Clinics
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Spinal Cord Stimulation Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Rechargeable Devices
10.1.2.Non-Rechargeable Devices
10.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Failed Back Surgery Syndrome (FBSS)
10.2.2.Complex Regional Pain Syndrome (CRPS)
10.2.3.Ischemic Pain
10.2.4.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers
10.3.3.Neuro Clinics
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Spinal Cord Stimulation Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Rechargeable Devices
11.1.2.Non-Rechargeable Devices
11.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Failed Back Surgery Syndrome (FBSS)
11.2.2.Complex Regional Pain Syndrome (CRPS)
11.2.3.Ischemic Pain
11.2.4.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers
11.3.3.Neuro Clinics
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Spinal Cord Stimulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Rechargeable Devices
12.1.2.Non-Rechargeable Devices
12.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Failed Back Surgery Syndrome (FBSS)
12.2.2.Complex Regional Pain Syndrome (CRPS)
12.2.3.Ischemic Pain
12.2.4.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers
12.3.3.Neuro Clinics
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Spinal Cord Stimulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Rechargeable Devices
13.1.2.Non-Rechargeable Devices
13.2.   Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Failed Back Surgery Syndrome (FBSS)
13.2.2.Complex Regional Pain Syndrome (CRPS)
13.2.3.Ischemic Pain
13.2.4.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers
13.3.3.Neuro Clinics
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Medtronic, Inc. (U.S.)
14.2.2.Boston Scientific Corporation (U.S.)
14.2.3.Jude Medical, Inc. (U.S.)
14.2.4.Synapse Biomedical, Inc. (U.S.)
14.2.5.Nevro Corporation (U.S.)
14.2.6.Neurosigma, Inc. (U.S.)
14.2.7.Neuropace, Inc. (U.S.)
14.2.8.Neuronetics, Inc. (U.S.)
14.2.9.Cyberonics, Inc. (U.S.)
14.2.10.BioControl Medical (Israel).
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel).

Related Industry Reports